Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of NuPathe Inc. Stockholders
16 Décembre 2013 - 11:11PM
Business Wire
Kirby McInerney LLP is investigating potential claims against
the Board of Directors of NuPathe Inc. (“NuPathe” or the “Company”)
(NASDAQ: PATH) concerning the proposed acquisition of the Company
by Endo Health Solutions Inc. (“Endo”) (NASDAQ: ENDP). Under the
terms of the definitive merger agreement, NuPathe stockholders will
receive $2.85 in cash for each share of NuPathe owned, valuing the
transaction at approximately $105 million.
The investigation concerns whether the NuPathe Board of
Directors violated its fiduciary duties by agreeing to the proposed
transaction and whether the $2.85 per share proposed consideration
adequately values NuPathe’s common stock.
If you are a NuPathe stockholder and wish to obtain additional
information, please contact J. Brandon Walker, Esq. by email
at bwalker@kmllp.com, by telephone at (212) 699-1145 or (888)
529-4787, or by filling out this contact form. There is no cost or
obligation to you.
Kirby McInerney LLP is a New York-based law firm concentrating
in securities, shareholder, whistleblower, antitrust and consumer
litigation. For additional information, please go to
www.kmllp.com.
Kirby McInerney LLPJ. Brandon Walker, Esq., 212-699-1145 /
888-529-4787bwalker@kmllp.com
Nupathe Inc. (MM) (NASDAQ:PATH)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Nupathe Inc. (MM) (NASDAQ:PATH)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
Real-Time news about Nupathe Inc. (MM) (NASDAQ): 0 recent articles
Plus d'articles sur Nupathe Inc. (MM)